Mixed Support For ABPI's UK Price Scheme Proposals

 
• By Leela Barham

The UK pharma industry body has set out bold proposals for a new drug pricing agreement from 2024, but not everyone is convinced. Generics companies are pressing for more of a say in the negotiations, while patient groups want to know more about how the deal would help improve access to medicines.

PS1807_Pills Under Scrutiny_141058420_1200.jpg
The ABPI's UK drug pricing scheme proposal is under close scrutiny • Source: Shutterstock

More from Europe

More from Geography